Oppenheimer Asset Management Inc. Has $1.26 Million Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Oppenheimer Asset Management Inc. boosted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 3.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 4,209 shares of the company’s stock after buying an additional 125 shares during the period. Oppenheimer Asset Management Inc.’s holdings in HCA Healthcare were worth $1,263,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in HCA. Whipplewood Advisors LLC acquired a new position in HCA Healthcare in the 4th quarter worth approximately $31,000. Legacy Investment Solutions LLC acquired a new stake in shares of HCA Healthcare in the third quarter worth $39,000. Activest Wealth Management lifted its stake in HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after acquiring an additional 125 shares in the last quarter. Capital Performance Advisors LLP purchased a new position in HCA Healthcare during the 3rd quarter valued at about $41,000. Finally, Pinnacle Bancorp Inc. boosted its holdings in shares of HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock worth $45,000 after purchasing an additional 50 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the transaction, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.60% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

HCA has been the subject of a number of research analyst reports. Wells Fargo & Company downgraded shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and cut their target price for the stock from $400.00 to $320.00 in a research report on Monday, November 25th. Morgan Stanley lowered their target price on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research note on Tuesday, December 17th. Royal Bank of Canada reduced their price target on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a report on Monday, January 27th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $405.00 price objective on shares of HCA Healthcare in a research report on Monday, January 27th. Finally, Truist Financial dropped their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $385.67.

HCA Healthcare Stock Performance

HCA opened at $311.11 on Tuesday. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The firm has a market capitalization of $77.26 billion, a P/E ratio of 14.16, a price-to-earnings-growth ratio of 1.10 and a beta of 1.64. The stock’s 50 day moving average price is $315.30 and its two-hundred day moving average price is $348.80. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the previous year, the company posted $5.90 earnings per share. On average, equities analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.93%. The ex-dividend date of this dividend is Monday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.